Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded <scp>DNA</scp>–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus

PaperCitations, authors & open-access status

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded <scp>DNA</scp>–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2018 year and hybrid oa status.

65
Citations
2018
Year
hybrid
OA Status

Related on ScholarIQ

Damon Bass
Author
Arthritis & Rheumatology
Journal
Systemic Lupus Erythematosus Research
Topic
Systemic Lupus Erythematosus Research
Topic
Multiple Sclerosis Research Studies
Topic
Liver Diseases and Immunity
Topic
470M+ articles · free account